Literature DB >> 19955177

Chemical induction of misfolded prion protein conformers in cell culture.

Sina Ghaemmaghami1, Julie Ullman, Misol Ahn, Susan St Martin, Stanley B Prusiner.   

Abstract

Prion-infected cells accumulate a heterogeneous population of aberrantly folded PrP conformers, including the disease-causing isoform (PrP(Sc)). We found that specific chemicals can modulate the levels of various PrP conformers in cultured cells. Positively charged polyamidoamines (dendrimers) eliminated protease-resistant (r) PrP(Sc) from prion-infected cells and induced the formation of insoluble, protease-sensitive PrP aggregates (designated PrP(A)). Larger, positively charged polyamidoamines more efficaciously induced the formation of PrP(A) and cleared rPrP(Sc), whereas negatively charged polyamidoamines neither induced PrP(A) nor cleared rPrP(Sc). Although the biochemical properties of PrP(A) were shown to be similar to protease-sensitive (s) PrP(Sc), bioassays of PrP(A) indicated that it is not infectious. Our studies argue that PrP(A) represents an aggregated PrP species that is off-pathway relative to the formation of rPrP(Sc). It remains to be established whether the formation of PrP(A) inhibits the formation of rPrP(Sc) by sequestering PrP(C) in the form of benign, insoluble aggregates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955177      PMCID: PMC2856248          DOI: 10.1074/jbc.M109.045112

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Evidence for synthesis of scrapie prion proteins in the endocytic pathway.

Authors:  D R Borchelt; A Taraboulos; S B Prusiner
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

2.  Isolation and characterization of a proteinase K-sensitive PrPSc fraction.

Authors:  Miguel A Pastrana; Gustavo Sajnani; Bruce Onisko; Joaquín Castilla; Rodrigo Morales; Claudio Soto; Jesús R Requena
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

3.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

4.  Prion clearance in bigenic mice.

Authors:  Jiri G Safar; Stephen J DeArmond; Katarzyna Kociuba; Camille Deering; Svetlana Didorenko; Essia Bouzamondo-Bernstein; Stanley B Prusiner; Patrick Tremblay
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

5.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

6.  A transmembrane form of the prion protein in neurodegenerative disease.

Authors:  R S Hegde; J A Mastrianni; M R Scott; K A DeFea; P Tremblay; M Torchia; S J DeArmond; S B Prusiner; V R Lingappa
Journal:  Science       Date:  1998-02-06       Impact factor: 47.728

7.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

8.  Mapping the prion protein using recombinant antibodies.

Authors:  R A Williamson; D Peretz; C Pinilla; H Ball; R B Bastidas; R Rozenshteyn; R A Houghten; S B Prusiner; D R Burton
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Cyclodextrins inhibit replication of scrapie prion protein in cell culture.

Authors:  Marguerite Prior; Sylvain Lehmann; Man-Sun Sy; Brendan Molloy; Hilary E M McMahon
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

Review 10.  A systematic review of prion therapeutics in experimental models.

Authors:  Clare R Trevitt; John Collinge
Journal:  Brain       Date:  2006-07-01       Impact factor: 13.501

View more
  14 in total

1.  Conformational transformation and selection of synthetic prion strains.

Authors:  Sina Ghaemmaghami; Joel C Watts; Hoang-Oanh Nguyen; Shigenari Hayashi; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Mol Biol       Date:  2011-08-04       Impact factor: 5.469

2.  Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice.

Authors:  Duo Lu; Kurt Giles; Zhe Li; Satish Rao; Elena Dolghih; Joel R Gever; Michal Geva; Manuel L Elepano; Abby Oehler; Clifford Bryant; Adam R Renslo; Matthew P Jacobson; Stephen J Dearmond; B Michael Silber; Stanley B Prusiner
Journal:  J Pharmacol Exp Ther       Date:  2013-08-21       Impact factor: 4.030

3.  Convergent replication of mouse synthetic prion strains.

Authors:  Sina Ghaemmaghami; David W Colby; Hoang-Oanh B Nguyen; Shigenari Hayashi; Abby Oehler; Stephen J DeArmond; Stanley B Prusiner
Journal:  Am J Pathol       Date:  2013-03       Impact factor: 4.307

4.  Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice.

Authors:  B Michael Silber; Satish Rao; Kimberly L Fife; Alejandra Gallardo-Godoy; Adam R Renslo; Deepak K Dalvie; Kurt Giles; Yevgeniy Freyman; Manuel Elepano; Joel R Gever; Zhe Li; Matthew P Jacobson; Yong Huang; Leslie Z Benet; Stanley B Prusiner
Journal:  Pharm Res       Date:  2013-02-16       Impact factor: 4.200

Review 5.  Developing Therapeutics for PrP Prion Diseases.

Authors:  Kurt Giles; Steven H Olson; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

6.  2-Aminothiazoles as therapeutic leads for prion diseases.

Authors:  Alejandra Gallardo-Godoy; Joel Gever; Kimberly L Fife; B Michael Silber; Stanley B Prusiner; Adam R Renslo
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

Review 7.  Therapeutic development of polymers for prion disease.

Authors:  Kenta Teruya; Katsumi Doh-Ura
Journal:  Cell Tissue Res       Date:  2022-03-21       Impact factor: 5.249

8.  Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice.

Authors:  Kurt Giles; David B Berry; Carlo Condello; Brittany N Dugger; Zhe Li; Abby Oehler; Sumita Bhardwaj; Manuel Elepano; Shenheng Guan; B Michael Silber; Steven H Olson; Stanley B Prusiner
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

9.  Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.

Authors:  B Michael Silber; Joel R Gever; Zhe Li; Alejandra Gallardo-Godoy; Adam R Renslo; Kartika Widjaja; John J Irwin; Satish Rao; Matthew P Jacobson; Sina Ghaemmaghami; Stanley B Prusiner
Journal:  Bioorg Med Chem       Date:  2013-09-18       Impact factor: 3.641

10.  Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).

Authors:  James M McCarthy; Markus Franke; Ulrike K Resenberger; Sibeal Waldron; Jeremy C Simpson; Jörg Tatzelt; Dietmar Appelhans; Mark S Rogers
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.